ChinaBio(R) LLC Release: Asia Registers Big Gain in Global Pharma R&D Spending; U.S. Drops

by Richard Daverman, PhD

January 7, 2014 -- Asia’s growth in biopharma R&D is changing the global landscape. The US, once dominant, saw its share of global spending on biopharma R&D drop from 51% to 45% over the six years that stretched from 2007 to 2012, according to a study by the University of Michigan Health System. Asia’s share rose from 18% to 24% during the same period. More details....

Help employers find you! Check out all the jobs and post your resume.